Reduced Plasma Apelin Levels in Patients with Autistic Spectrum Disorder

Archives of Medical Research

Volumn 38, Issue 1, 2007, Pages 70-74

  Boso, Marianna ^a   Emanuele, Enzo ^a   Politi, Pierluigi ^a   Pace, Alessandro ^a   Arra, Mariarosa ^a   Ucelli di Nemi, Stefania ^a   Barale, Francesco ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Apelin; Autistic spectrum disorders; Neuropeptides; Vasopressin

Indexed keywords

APELIN; NEUROPEPTIDE; RECEPTOR; VASOPRESSIN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILDHOOD AUTISM RATING SCALE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GIANT CELL; HUMAN; HYPOTHALAMUS; LINEAR REGRESSION ANALYSIS; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RATING SCALE;

ADOLESCENT; ADULT; AUTISTIC DISORDER; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; VASOPRESSINS;

EID: 33845424135     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.08.003     Document Type: Article

References (24)

1. Lim M.M., Bielsky I.F., and Young L.J. Neuropeptides and the social brain: potential rodent models of autism. Int J Dev Neurosci 23 (2005) 235-243
2. Young L.J., Pitkow L.J., and Ferguson J.N. Neuropeptides and social behavior: animal models relevant to autism. Mol Psychiatry 7 (2002) S38-S39
3. Insel T.R., O'Brien D.J., and Leckman J.F. Oxytocin, vasopressin, and autism: is there a connection?. Biol Psychiatry 45 (1999) 145-157
4. Bielsky I.F., Hu S.B., Ren X., Terwilliger E.F., and Young L.J. The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study. Neuron 47 (2005) 503-513
5. Bielsky I.F., Hu S.B., Szegda K.L., Westphal H., and Young L.J. Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology 29 (2004) 483-493
6. Wassink T.H., Piven J., Vieland V.J., Pietila J., Goedken R.J., Folstein S.E., et al. Examination of AVPR1a as an autism susceptibility gene. Mol Psychiatry 9 (2006) 968-972
7. Yirmiya N., Rosenberg C., Levi S., Salomon S., Shulman C., Nemanov L., et al. Association between the arginine vasopressin 1a receptor (AVPR1a) gene and autism in a family-based study: mediation by socialization skills. Mol Psychiatry 11 (2006) 488-494
8. Momeni N., Nordstrom B.M., Horstmann V., Avarseji H., and Sivberg B.V. Alterations of prolyl endopeptidase activity in the plasma of children with autistic spectrum disorders. BMC Psychiatry 5 (2005) 27
9. Thompson R.R., George K., Walton J.C., Orr S.P., and Benson J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci USA 103 (2006) 7889-7894
10. Matsuoka T., Sumiyoshi T., Tanaka K., Tsunoda M., Uehara T., Itoh H., et al. NC-1900, an arginine-vasopressin analogue, ameliorates social behavior deficits and hyperlocomotion in MK-801-treated rats: therapeutic implications for schizophrenia. Brain Res 1053 (2005) 131-136
11. Emanuele E. Autism conceptualized as a vasopressin resistance syndrome. Med Hypotheses 66 (2006) 1245
12. Reaux A., De Mota N., Skultetyova I., Lenkei Z., El Messari S., Gallatz K., et al. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem 77 (2001) 1085-1096
13. De Mota N., Reaux-Le Goazigo A., El Messari S., Chartrel N., Roesch D., Dujardin C., et al. Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. Proc Natl Acad Sci USA 101 (2004) 10464-10469
14. Reaux A., Gallatz K., Palkovits M., and Llorens-Cortes C. Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience 113 (2002) 653-662
15. Reaux-Le Goazigo A., Morinville A., Burlet A., Llorens-Cortes C., and Beaudet A. Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology 145 (2004) 4392-4400
16. Schopler E., Reichler R.J., DeVellis R.F., and Daly K. Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). J Autism Dev Disord 10 (1980) 91-103
17. Perry A., Condillac R.A., Freeman N.L., Dunn-Geier J., and Belair J. Multi-site study of the Childhood Autism Rating Scale (CARS) in five clinical groups of young children. J Autism Dev Disord 35 (2005) 625-634
18. Ellinor P.T., Low A.F., and Macrae C.A. Reduced apelin levels in lone atrial fibrillation. Eur Heart J 27 (2006) 222-226
19. Malyszko J., Malyszko J.S., Kozminski P., and Mysliwiec M. Apelin and cardiac function in hemodialyzed patients: possible relations?. Am J Nephrol 26 (2006) 121-126
20. Wolff K., Tsapakis E.M., Winstock A.R., Hartley D., Holt D., Forsling M.L., et al. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. J Psychopharmacol 20 (2006) 400-410
21. Jaszberenyi M., Bujdoso E., and Telegdy G. Behavioral, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 (2004) 811-816
22. Corbett B.A., Mendoza S., Abdullah M., Wegelin J.A., and Levine S. Cortisol circadian rhythms and response to stress in children with autism. Psychoneuroendocrinology 31 (2006) 59-68
23. Curin J.M., Terzic J., Petkovic Z.B., Zekan L., Terzic I.M., and Susnjara I.M. Lower cortisol and higher ACTH levels in individuals with autism. J Autism Dev Disord 33 (2003) 443-448
24. Richdale A.L., and Prior M.R. Urinary cortisol circadian rhythm in a group of high-functioning children with autism. J Autism Dev Disord 22 (1992) 433-437